Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)
This study has been terminated.
(This study was terminated because it was unlikely to have sufficient power to show a difference with therapy on an interim analysis.)
Sponsor:
Emory University
Collaborator:
Pfizer
Information provided by:
Emory University
ClinicalTrials.gov Identifier:
NCT00252967
First received: November 14, 2005
Last updated: October 27, 2009
Last verified: March 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | October 2009 |
| Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Negi, S., Shukrullah, I., Veladar, E., Bloom, H., Jones, D., S.C. Dudley, Jr. (2010). Statin Therapy for Prevention of Atrial Fibrillation Trial (SToP AF trial). [Abstract]. ACC 2010. 10-A-11608-ACC.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):